Instrument Engineer
About the job
- A minimum of 3 years of relevant professional experience.
- Experience designing life science research instruments involving mechanical stages, precision optical assemblies, fluidics, structural components, housing parts, and computer control.
- Ability to understand requirements and generate design concepts.
- Ability to select and specify components and make make-or-buy decisions.
- Ability to develop 3D models, fabrication drawings, and assembly drawings.
- Ability to build and test prototypes.
- Ability to interface with purchasing and suppliers.
- Ability to maintain product documentation.
- Ability to release documentation for manufacturing.
- Design research instruments for performing biochemical reactions and signal detection.
About the company
Centrillion Technologies develops tools for genomic studies, including sequencing, bioinformatics, and a new generation of DNA chips designed for high-density, high-quality probes that work with sequencing. Its products include ATOM, a high-throughput detection system, and VirusHunter MVP, a pathogen-detection assay, along with sequencing and droplet digital PCR services for researchers and drug discovery groups. It differentiates itself by offering integrated genomics hardware, assays, and services with DNA chips optimized for large-scale analysis that complement sequencing workflows. Its goal is to enable broad, scalable genomic studies to accelerate drug discovery, personalized medicine, and molecular diagnostics.
Company Size
51-200
Company Stage
Series B
Total Funding
$24.3M
Headquarters
Palo Alto, California
Founded
2009
Get referred to Centrillion Technologies
See people who can refer or advise you
Simplify's Take
What believers are saying
- September 2026 site updates show active product marketing and service availability.
- Centrillion’s August 2026 AI messaging targets genome, cell, and tissue data buyers.
- The platform keeps multiple revenue paths: research chips, diagnostics, and sequencing services.
What critics are saying
- VirusHunter MVP remains only through Molecular Vision Laboratories as of August 2026.
- Centrillion shows no fresh 2025-2026 financing, suggesting constrained commercial scale.
- Illumina, Thermo Fisher, and Oxford Nanopore can crush adoption if chip volumes lag.
What makes Centrillion Technologies unique
- Centrillion’s September 2026 chips combine 50,000-2 million variants with sequencing workflows.
- VirusHunter pairs pathogen detection and whole-genome sequencing on ATOM and QuadCore chips.
- The company still owns a rare integrated stack: chips, assays, and clinical-lab services.
Help us improve and share your feedback! Did you find this helpful?